The chemical class of COPB activators is diverse, encompassing compounds that influence various aspects of cellular transport and dynamics. These chemicals interact with different components of the cell's cytoskeleton, vesicular transport systems, and organelle formation processes, which in turn can indirectly affect the function of COPB. For example, Brefeldin A and Golgicide A, by targeting components critical for Golgi structure and function, can modulate COPB activity by altering vesicular trafficking and coatomer assembly. Nocodazole, through its action on microtubules, can indirectly influence COPB by changing the dynamics of vesicular movement and distribution within the cell. Compounds like Forskolin and Monensin modify intracellular signaling and ion concentration, respectively, which can impact vesicle formation and trafficking. These changes could lead to compensatory or adaptive changes in COPB function, as the cell attempts to maintain its intracellular transport and membrane trafficking homeostasis. Additionally, Cytochalasin D, Dynasore, and Latrunculin A, by influencing actin and dynamin dynamics, can impact the processes of vesicle formation and release, thereby indirectly modulating COPB activity.
Moreover, agents such as SecinH3 and ML141, which target GTPase signaling, play a role in regulating aspects of vesicular trafficking that could indirectly influence COPB. The modulation of these pathways leads to alterations in vesicle formation and transport, which are crucial for the normal function of the COPI coatomer complex, of which COPB is an integral part. Similarly, Jasplakinolide and Wiskostatin, through their effects on actin dynamics and N-WASP activity, contribute to the regulation of vesicular transport processes, potentially impacting the function of COPB.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
A microtubule-depolymerizing agent that affects intracellular transport and Golgi distribution, potentially influencing COPB function by altering vesicle dynamics. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases cAMP levels, influencing cellular processes including vesicular trafficking, which can impact COPB activity indirectly. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
An ionophore altering intracellular pH and ion concentrations, affecting vesicle formation and trafficking, potentially influencing COPB activity. | ||||||
Cytochalasin C | 22144-76-9 | sc-202118 sc-202118A | 1 mg 5 mg | $122.00 $512.00 | 1 | |
Inhibits actin polymerization, impacting cell shape and motility, potentially affecting COPB function in vesicular trafficking. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Inhibits dynamin, a GTPase involved in vesicle scission, potentially affecting COPB function by altering vesicle formation and release. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
Inhibits Cdc42, a small GTPase affecting actin dynamics, which can influence vesicular trafficking, potentially modulating COPB activity. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Disrupts actin filaments, impacting cell shape and vesicle movement, potentially influencing COPB function indirectly. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Stabilizes actin filaments, affecting vesicle trafficking, potentially modulating COPB activity. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Inhibits N-WASP, impacting actin polymerization and vesicular trafficking, potentially influencing COPB function. | ||||||